BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 20610140)

  • 1. Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
    Storch EA; Lewin AB; De Nadai AS; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2010 Jul; 49(7):708-17. PubMed ID: 20610140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Children's Yale-Brown Obsessive-Compulsive Scale: item structure in an outpatient setting.
    McKay D; Piacentini J; Greisberg S; Graae F; Jaffer M; Miller J; Neziroglu F; Yaryura-Tobias JA
    Psychol Assess; 2003 Dec; 15(4):578-81. PubMed ID: 14692851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats.
    Storch EA; Murphy TK; Adkins JW; Lewin AB; Geffken GR; Johns NB; Jann KE; Goodman WK
    J Anxiety Disord; 2006; 20(8):1055-70. PubMed ID: 16503111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
    Skarphedinsson G; De Nadai AS; Storch EA; Lewin AB; Ivarsson T
    Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):47-55. PubMed ID: 27209422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting therapy outcome in patients with early and late obsessive-compulsive disorder (EOCD and LOCD).
    Langner J; Laws M; Röper G; Zaudig M; Hauke W; Piesbergen C
    Behav Cogn Psychother; 2009 Oct; 37(5):485-96. PubMed ID: 19796435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Larson MJ; Bloss CS; Geffken GR; Jacob ML; Murphy TK; Goodman WK
    Acta Psychiatr Scand; 2008 Jan; 117(1):67-75. PubMed ID: 17986317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.
    Scahill L; Riddle MA; McSwiggin-Hardin M; Ort SI; King RA; Goodman WK; Cicchetti D; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):844-52. PubMed ID: 9183141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder administered in regular outpatient clinics.
    Valderhaug R; Larsson B; Götestam KG; Piacentini J
    Behav Res Ther; 2007 Mar; 45(3):577-89. PubMed ID: 16836977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.
    Storch EA; Murphy TK; Geffken GR; Soto O; Sajid M; Allen P; Roberti JW; Killiany EM; Goodman WK
    Psychiatry Res; 2004 Nov; 129(1):91-8. PubMed ID: 15572188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting.
    Yucelen AG; Rodopman-Arman A; Topcuoglu V; Yazgan MY; Fisek G
    Compr Psychiatry; 2006; 47(1):48-53. PubMed ID: 16324902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder.
    Cullen B; Brown CH; Riddle MA; Grados M; Bienvenu OJ; Hoehn-Saric R; Shugart YY; Liang KY; Samuels J; Nestadt G
    Depress Anxiety; 2007; 24(2):130-8. PubMed ID: 16892417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manual-Driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a pilot study.
    Thienemann M; Martin J; Cregger B; Thompson HB; Dyer-Friedman J
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1254-60. PubMed ID: 11699798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor analytic study of the Children's Yale-Brown Obsessive-Compulsive Scale.
    Storch EA; Murphy TK; Geffken GR; Bagner DM; Soto O; Sajid M; Allen P; Killiany EM; Goodman WK
    J Clin Child Adolesc Psychol; 2005 Jun; 34(2):312-9. PubMed ID: 15901231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor structure and reliability of the Spanish adaptation of the Children's Yale-Brown Obsessive-Compulsive Scale--Self Report (CY-BOCS-SR)].
    Godoy A; Gavino A; Valderrama L; Quintero C; Cobos MP; Casado Y; Sosa MD; Capafons JI
    Psicothema; 2011 Apr; 23(2):330-5. PubMed ID: 21504689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients.
    de Haan L; Hoogeboom B; Beuk N; Wouters L; Dingemans PM; Linszen DH
    Psychopharmacol Bull; 2006; 39(1):25-30. PubMed ID: 17065972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
    van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
    J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining clinical judgment of treatment outcome in obsessive-compulsive disorder.
    Lewin AB; De Nadai AS; Park J; Goodman WK; Murphy TK; Storch EA
    Psychiatry Res; 2011 Feb; 185(3):394-401. PubMed ID: 20846725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.